|
EP0200024B1
(de)
*
|
1985-04-30 |
1992-07-01 |
ARZNEIMITTELWERK DRESDEN GmbH |
3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
|
AU2001280091A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Wockhardt Limited |
Inhibitors of cellular efflux pumps of microbes
|
|
US7074794B2
(en)
*
|
2000-08-10 |
2006-07-11 |
Mitsubishi Pharma Corporation |
Proline derivatives and the use thereof as drugs
|
|
JP2007507514A
(ja)
*
|
2003-09-30 |
2007-03-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キノキサリン化合物
|
|
EP1836189A1
(en)
*
|
2005-01-06 |
2007-09-26 |
AstraZeneca AB |
Novel pyridine compounds
|
|
EP1987827A1
(en)
*
|
2006-02-20 |
2008-11-05 |
Takeda Pharmaceutical Company Limited |
Novel pharmaceutical
|
|
TW200815426A
(en)
*
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
|
MX2009000577A
(es)
*
|
2006-07-14 |
2009-03-09 |
Schering Corp |
Compuestos de piperazina sustituida heterociclica con actividad antagonista de cxcr3.
|
|
TW201204727A
(en)
*
|
2010-03-10 |
2012-02-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
JP2011246461A
(ja)
*
|
2010-04-27 |
2011-12-08 |
Mitsubishi Tanabe Pharma Corp |
新規アミド誘導体を含有する医薬組成物
|
|
EA201390476A1
(ru)
*
|
2010-09-28 |
2013-08-30 |
Бристол-Майерс Сквибб Компани |
Новые пиперазиновые аналоги с замещенными гетероарильными группами в качестве противовирусных средств широкого применения против гриппа
|
|
EP3371164B1
(en)
*
|
2015-11-06 |
2022-03-16 |
Neurocrine Biosciences, Inc. |
N-[2-(1-benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1-carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases
|
|
WO2017097927A1
(en)
*
|
2015-12-11 |
2017-06-15 |
Syngenta Participations Ag |
Pesticidally active 1,2,4-triazole derivatives
|
|
US20190119236A1
(en)
*
|
2016-02-23 |
2019-04-25 |
Portola Pharmaceuticals, Inc. |
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
WO2017160069A1
(ko)
*
|
2016-03-15 |
2017-09-21 |
재단법인 의약바이오컨버젼스연구단 |
신규한 벤젠설폰아미드 유도체 및 이의 용도
|
|
MX393606B
(es)
*
|
2016-12-30 |
2025-03-19 |
Mitobridge Inc |
Inhibidores de poli-adp ribosa polimerasa (parp)
|
|
US11518764B2
(en)
*
|
2018-02-06 |
2022-12-06 |
Ontario Institute For Cancer Research (Oicr) |
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction
|
|
JP7637328B2
(ja)
*
|
2019-02-07 |
2025-02-28 |
ベイジーン リミテッド |
Ｔｌｒ７アゴニストとしてのイミダゾ［２，１－ｆ］［１，２，４］トリアジン－４－アミン誘導体
|
|
WO2021067859A1
(en)
*
|
2019-10-03 |
2021-04-08 |
Tenaya Therapeutics, Inc. |
5-fluoronicotinamide derivatives and uses thereof
|
|
WO2021127333A1
(en)
*
|
2019-12-19 |
2021-06-24 |
Casma Therapeutics, Inc. |
Trpml modulators
|